MBRX
Moleculin Biotech, Inc.
Next earnings Aug 10, 2026 · consensus $-1.49 EPS
Last earnings -4.1% on 2026-05-15
$2.99▼ -55.21%
over 1Y
L $1.96EODHDH $20.89
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today—
1W+3.8%
1M+22.0%
3M+23.0%
YTD-17.4%
1Y-55.2%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 9 analysts
Buy
Conservative balance sheet (liabilities/equity 0.47x).
Moleculin Biotech, Inc. shows $0.00 in FY2025 revenue, and -223.6% ROE.
Sources: SEC EDGAR (CIK 0001659617, latest 10-Q filed 2026-05-14) · as of 6/26/2026, 1:08:14 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.